- About
- Home
- Introduction
- Statistics
- Programs
- Dignet
- Gene
- GenePair
- BioSummarAI
- Help & Docs
- Documents
- Help
- FAQs
- Links
- Acknowledge
- Disclaimer
- Contact Us
Gene Information
Gene symbol: KCNJ6
Gene name: potassium inwardly-rectifying channel, subfamily J, member 6
HGNC ID: 6267
Synonyms: Kir3.2, GIRK2, KATP2, BIR1, hiGIRK2
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | BRCA2 | 1 hits |
| 2 | CCKBR | 1 hits |
| 3 | CDX2 | 1 hits |
| 4 | FABP2 | 1 hits |
| 5 | GCG | 1 hits |
| 6 | GCKR | 1 hits |
| 7 | GLP1R | 1 hits |
| 8 | GPD2 | 1 hits |
| 9 | HK1 | 1 hits |
| 10 | HK2 | 1 hits |
| 11 | INS | 1 hits |
| 12 | ISL1 | 1 hits |
| 13 | KCNJ3 | 1 hits |
| 14 | KCNJ5 | 1 hits |
| 15 | LDLR | 1 hits |
| 16 | PCSK2 | 1 hits |
| 17 | PDLIM5 | 1 hits |
| 18 | PFKL | 1 hits |
| 19 | PKLR | 1 hits |
| 20 | PKM2 | 1 hits |
| 21 | PPP1CB | 1 hits |
| 22 | PPP1R3C | 1 hits |
| 23 | PPP5C | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 7626127 | The levels of KATP-2 mRNA were reduced by 34% in islets from diabetic Zucker diabetic fatty male rats, a model of non-insulin dependent diabetes mellitus, compared to their lean nondiabetic littermates (p < 0.05), suggesting that decreased expression of KATP-2 may contribute to beta-cell dysfunction in this animal model. |
| 2 | 7729621 | We screened a hamster insulinoma cDNA library by low-stringency hybridization with a probe coding for the G-protein-coupled inwardly rectifying K+ channel GIRK1/KGA and isolated clones encoding a protein, KATP-2, whose sequence is 90% similar to that of the recently described KATP-1, an ATP-sensitive K+ channel expressed in heart and other tissues. |
| 3 | 9166680 | Loci included the G-protein-coupled inwardly rectifying potassium channels expressed in beta-cells (KCNJ3 and KCNJ7), glucagon (GCG), glucokinase regulatory protein (GCKR), glucagon-like peptide I receptor (GLP1R), LIM/homeodomain islet-1 (ISL1), caudal-type homeodomain 3 (CDX3), proprotein convertase 2 (PCSK2), cholecystokinin B receptor (CCKBR), hexokinase 1 (HK1), hexokinase 2 (HK2), mitochondrial FAD-glycerophosphate dehydrogenase (GPD2), liver and muscle forms of pyruvate kinase (PKL, PKM), fatty acid-binding protein 2 (FABP2), hepatic phosphofructokinase (PFKL), protein serine/threonine phosphatase 1 beta (PPP1CB), and low-density lipoprotein receptor (LDLR). |